United States · FDA National Drug Code directory
Dapsone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 83209-566_20e8edf4-4458-c1da-e063-6394a90aa891
- Product NDC
- 83209-566
- Form
- TABLET
- Composition / generic term
- dapsone
- Labeler
- Boswell Pharmacy Services LLC d/b/a BPS Wholesale
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240830
- Source listing expiry
- 20261231
Source-listed ingredients
- DAPSONE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BLISTER PACK (83209-566-30) · 83209-566-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →